What is Neuralink?
The American neurotechnology business Neuralink Corporation, located in Fremont, California, creates implanted brain-computer interfaces (BCIs). Neuralink was established in 2016 by Elon Musk and a group of seven scientists and engineers, and it was initially made public in March 2017.
How does it work?
Neuralink wants to utilize its microchips to enable certain impaired individuals to use computers and mobile technologies, as well as to treat illnesses like paralysis and blindness.
The chips, which have been tested on monkeys, are intended to decipher brain impulses and transmit knowledge to gadgets through Bluetooth.
Additionally, Mr. Musk has already asserted that the planned technology would allay worries that AI will supplant people in the future.
The Neuralink project, led by Elon Musk, has reported a substantial advancement in its goal of enabling brain-to-computer communication.
Technology
Although public documents indicated that Neuralink had attempted to establish an animal testing facility in San Francisco, it was reported in 2018 that the company “remained highly secretive about its work”; it later began conducting research at the University of California, Davis. The Neuralink team presented the technology of the first prototype they had been working on live to the public in 2019 at the California Academy of Sciences. A neurosurgical robot will execute the procedures using ultra-thin probes put into the brain, and a high-density electronic system that can analyze information from neurons will be used. It is based on technologies created at UC Berkeley and UC San Francisco.\
READ ALSO-Google Launched Pixel 6a, in India at 43,999 INR.
Collaboration with FDA
The US Food and Drug Administration (FDA) has given the brain-machine interface business permission to move forward with its first-in-human clinical investigation. This endorsement is seen as a significant advancement for Neuralink’s ground-breaking technology.
When Neuralink announced that it had received FDA clearance to start its first clinical trial with human subjects, they expressed their joy and happiness. Neuralink revealed this important breakthrough via a tweet, which Elon Musk then retweeted.
The business thanked the FDA and stressed the cooperation between its personnel and the regulatory body.
Functioning of Neuralink-
While the clinical trial’s recruiting process has not yet started, Neuralink intends to promote direct brain-computer connection. The implanted Neuralink gadget, according to Elon Musk, would allow users to communicate with computers by using their brains.
The firm has advanced significantly, as shown by implantation tests carried out on monkeys, where the creatures were able to use cursors and play video games using the Neuralink interface.
The technology developed by Neuralink has a plethora of possible uses. Musk imagines a future in which people with disabilities may regain lost abilities like movement and eyesight.
Musk has expressed worries about the eventual dominance of artificial intelligence and stated that the company’s ultimate objective is to improve human intellectual capacity through brain-machine interfaces, which goes beyond medical uses.
Given Musk’s history of making bold promises, Neuralink’s development has been widely monitored. The current FDA clearance is a huge step towards realizing the potential of this ground-breaking technology, despite the fact that the early forecasts for human tests in 2020 were not realized.
The market for brain-machine interfaces is not dominated by Neuralink. The first brain-machine interface to be successfully implanted in the United States was announced by Synchron, a firm that specializes in such devices, earlier this year
